Tag: vaccine

Posted on

New Vaccine Findings Pose Tough Questions for Parents of Young Children

New Vaccine Findings Pose Tough Questions for Parents of Young Children

For American parents, specially those with young kids, the last few of months have been dizzying and further than disheartening.

In early February, federal regulators announced that they would appraise Pfizer-BioNTech’s coronavirus vaccine for the youngest youngsters — only to scrap that plan 10 times afterwards, citing doubts about the vaccine’s efficiency in that age group.

Shortly just after, scientists claimed that the vaccine was only weakly protective against infection with the Omicron variant among little ones aged 5 to 11 and that it appeared to offer you small defense from reasonable Covid ailment among adolescents aged 12 to 17.

On Monday, citing these details, Florida’s surgeon general declared that healthy kids have to have not be immunized, advice that Jen Psaki, the White House push secretary, referred to as “deeply disturbing.”

By means of it all, professionals have continued to endorse vaccines, noting that although the Omicron variant may perhaps be ready to penetrate immune defenses and infect people today, the vaccines continue to stop critical sickness and loss of life — and may perhaps do so for yrs.

The Centers for Illness Manage and Avoidance located that history quantities of kids below 5 experienced been hospitalized in the course of the Omicron surge, underscoring the want for vaccines for all those youngsters. But the company has since mentioned that 90 {cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of People in america can safely and securely end wearing masks in public indoor areas, even in schools with younger young children.

Who could blame dad and mom for sensation bewildered?

“The component that is confusing is like there’s no lengthier any crystal clear, proper response,” said Anne Gonzalez, a 41-calendar year-previous mother of two who manages volunteers for a huge spiritual nonprofit in St. Louis. “I’ve come to the level that all I can do is what I imagine is right for my family members.”

Luckily, the coming months should really deliver some clarity. Both equally Pfizer and Moderna program to report effects from trials of their vaccines in youthful kids. The success, if beneficial, should really guide to a new spherical of regulatory critique, probably as early as April, that may perhaps perfectly enable vaccinations for tens of millions of kids.

But these results will arrive as the Omicron variant fades in the United States, complicating parental selections about whether to vaccinate youngsters.

Much less than one particular in four youngsters aged 5 to 11 are now completely vaccinated. Much more than 50 {cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of adolescents 12 to 17 are thoroughly vaccinated, but only about 12 p.c have been given a booster dose. All those percentages are even lessen in rural locations of the United States.

Kids are fewer possible to knowledge health issues, so the harmony of chance and gain was under no circumstances the identical as for adults. And by now, as considerably as 95 per cent of the place has some degree of security from the virus due to the fact of vaccines or prior infection, according to current details from the C.D.C.

Experts fear that the most current findings have made it even much more difficult to persuade some parents to immunize their children.

“We should be upset with the info — we desire it could be better,” reported Luciana Borio, a former performing chief scientist at the Meals and Drug Administration. “But in the in close proximity to phrase, it is essential for mothers and fathers to nonetheless vaccinate small children.”

The place might still see a surge in the tumble or wintertime, and the most effective safety for small children will be to have had at minimum two photographs ahead of then, she stated.

The vaccines are continuing to stop critical sickness and death, even with the Omicron variant. That trend is specifically very clear at hospitals, reported Dr. James Campbell, a doctor at the College of Maryland University of Drugs and a member of the American Academy of Pediatrics committee on infectious diseases.

Among the his pediatric clients who had been sick more than enough to have to have a mechanical ventilator or die, “every one just one of them was unvaccinated,” Dr. Campbell said.

The modern research recommend that the dilemma is not so much the vaccine as the dose.

In the trials in older people in 2020, vaccine companies built most effective guesses at the ideal dose and opted for brief intervals amongst the pictures to defend folks as speedily as feasible during the original surge.

The Pfizer-BioNTech and Moderna vaccines proved to be harmless and powerfully protecting in medical trials and were speedily licensed for use. But the trials in little ones ended up complex by the arrival of the Delta and Omicron variants, and the vaccine appeared to be less protective in small children aged 2 to 4.

At the second, the Pfizer-BioNTech vaccine is the only a single authorized for little ones. (The vaccines produced by Moderna and Johnson & Johnson are approved only for grownups.)

In the Pfizer trials, adolescents aged 12 to 17 have been offered 30 micrograms, the similar dose offered to older people. But children aged 5 to 11 received 10 micrograms, and individuals 6 months to 5 years aged gained just three micrograms.

These doses might have been far too lower to rouse an ample and lasting response. But federal officials who have found the data told The New York Moments that better doses manufactured way too several fevers in youngsters.

What to do when you simply cannot administer a dose high plenty of to protect kids versus the Omicron variant because of aspect consequences? That is the difficulty that researchers and federal officers are now wrestling with.

Pfizer and BioNTech are now testing a 3rd dose in kids below 12 to determine regardless of whether it can provide the stage of security that two doses could not. The F.D.A. is continue to analyzing the Moderna vaccine for use in young children 6 to 11. Very last 7 days, the agency turned down an software for authorization of the Indian-produced vaccine Covaxin for young children.

There are other Covid vaccines, like individuals produced by Novavax and Sanofi, that may possibly turn out to get the job done effectively in children. Federal health officers really should take into consideration all of these selections and take a look at whether or not a different dose or a extended interval concerning doses would strengthen the immune response, experts claimed.

“It would seem to me that vaccines for little ones are having for a longer period than they should, presented the relevance of guarding that populace,” Dr. Borio said. “The sooner we re-energize our research for safe and sound and effective vaccines for children, the far better off we’ll be.”

The disappointing findings, alongside with the receding Omicron surge, have significantly complex coverage choices for area overall health officials.

Countering Florida’s suggestions, Louisiana and California will demand schoolchildren to be immunized by tumble 2022, and the District of Columbia established a deadline of March 1 for pupils 12 and more mature to be absolutely vaccinated.

Other states might undertake very similar insurance policies but are probably to do so only if the F.D.A. grants the vaccine comprehensive approval for use in schoolchildren, claimed Hemi Tewarson, executive director at the Countrywide Academy for Point out Wellbeing Coverage, a nonpartisan firm.

“For a good deal of them, that’s heading to be crucial for demanding vaccines as a mandate,” she claimed.

A college vaccine mandate would relieve the fears of lots of households with small children who have professional medical vulnerabilities.

Nearly each and every member of Heather Keever’s family members, including her son, Wesley, 14, has heart illness, significant blood tension and kidney illness. But because they are not technically immunocompromised, they have not qualified for lodging at do the job or at college, said Ms. Keever, 42, a guide in suburban Chicago.

“They fail to remember that there is some of us who just basically simply cannot get the mask off,” at least until eventually the fees tumble a great deal more, she explained. “I felt like I didn’t make any difference and I was not crucial and I was arguably disposable. And I nonetheless do.”

Some scientists, too, have said they would carry on to wear masks until the quantities dip because of the hazard of an infection.

Because the youngest youngsters have not nonetheless been vaccinated, “I’d be very hesitant to check with a baby beneath 5 to take away masks indoors,” mentioned Akiko Iwasaki, an immunologist at Yale College who studies long Covid, the cluster of signs and symptoms that can persist very long after the acute an infection is settled.

Presented the muddled outcomes on the performance of vaccines and the combined messages on the gains of masks, family members are weighing dangers on their very own — and coming to really various conclusions.

Jennifer Steinberg, a administration guide in Wilmington, Del., has two daughters who break up their time with her and their immunocompromised father.

“Yes, good, it shields in opposition to intense ailment,” Ms. Steinberg said of the vaccine. “But if your children are nevertheless likely to get contaminated, this is a large disruption to family members life. I’m in all probability likely to keep masked for the foreseeable future.”

Katie Sunderland of Arlington, Va., has extensive been prepared to give up masks. If her young children, 7 and 5, do come to be contaminated, “that’s a trade-off I’m Ok with if they are capable to unmask and see faces,” she mentioned.

“I’m not confident that carrying a mask would noticeably minimize the threat of acquiring Covid in any case — specifically not the form of masks I see most youngsters wearing,” Ms. Sunderland, 37, explained. “It does not make sense to me to impede my kids’ advancement for that incredibly, incredibly, quite minimal risk.”

But many other mothers and fathers are continue to not sure of what to do. Ms. Gonzalez has a niece and nephew who have congenital heart defects and issues with lung ability, and she will carry on to have on masks to safeguard them, she reported.

But if her son’s university drops the mask requirement, “we don’t know what we’re likely do but.”

Posted on

Covid-19 vaccine ‘may not benefit’ healthy 5- to 17-year-olds, says New Florida Department of Health guidance

Covid-19 vaccine ‘may not benefit’ healthy 5- to 17-year-olds, says New Florida Department of Health guidance

“Centered on at present accessible info, healthy young children aged 5 to 17 might not benefit from obtaining the now offered COVID-19 vaccine. The Department endorses that kids with fundamental circumstances are the very best candidates for the COVID-19 vaccine,” it states. “Parents are inspired to discuss the hazards and advantages with their kid’s health and fitness care practitioner when evaluating whether their youngster should get a COVID-19 vaccine, significantly for children with fundamental health and fitness ailments or comorbidities.”

Florida is the first condition to split from US Facilities for Sickness Handle and Prevention recommendations that anyone age 5 and older receive the vaccine.

Florida Surgeon Common Dr. Joseph Lapado introduced the measure on Monday during a roundtable dialogue hosted by Gov. Ron DeSantis. Conveying the final decision, DeSantis stated Ladapo was concerned that the vaccine was “staying pushed on individuals.”

“We are not just likely to observe the CDC in the point out of Florida,” he reported. “We are going to do our own things.”

The steerage released Tuesday states that the challenges of the vaccine outweigh its gains in little ones who never have fundamental wellness disorders. It cites stories of amplified incidence of myocarditis — inflammation of the heart muscle — in 16- and 17-yr-olds who acquired the Covid-19 vaccine.

The study that the guidance takes advantage of to aid this concern also discovered that the possibility of myocarditis is exceptional, figuring out 105.9 conditions for each 1 million doses of the mRNA vaccine provided in 16- to 17-12 months-olds.
Florida surgeon general favorably recommended after Democrats walk out of confirmation hearing
The guidance also cites knowledge from a scientific demo posted in the New England Journal of Medication that discovered no conditions of intense Covid-19 in a group of young children ages 5 to 11, irrespective of whether they obtained the Pfizer/BioNTech Covid-19 vaccine or a placebo. Nonetheless, that examine discovered that the vaccine was 90.7{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} productive in avoiding Covid-19 an infection.
The section also dependent the steerage off a New York-dependent review that found vaccine performance for small children ages 5 to 17 dropped appreciably all through the Omicron surge. But that exploration concluded that the vaccine ongoing to be effective towards extreme ailment in children. That study is a preprint and has not been published in a peer-reviewed skilled journal, so a notice in daring at the best of the review advises that it should really not be utilized to information scientific follow.
Wellness industry experts have been quite important of the department’s tips.
CDC director rebukes DeSantis for scolding high school students over masks: 'It is absolutely their choice'

In a statement Tuesday, Dr. Daniel P. McQuillen, president of the Infectious Illnesses Modern society of The us, stated his group “strongly opposes the point out of Florida’s determination to set politics around the wellness and security of children. The Florida Surgeon General’s determination to suggest versus COVID-19 vaccination for balanced little ones flies in the experience of the most effective healthcare steerage and only serves to additional sow distrust in vaccines that have established to be the safest, most powerful protection towards intense COVID-19 illness, hospitalization and death.”

The head of the University of Florida’s well being method despatched an electronic mail Tuesday to staff members that distanced the healthcare network from Ladapo in mild of Monday’s announcement.

Dr. David Nelson, the senior vice president for health affairs at the university and president of UF Well being, informed team that Ladapo does not speak for the university and acknowledged that his viewpoints clash with those of other health care professionals. Ladapo is a professor at the University of Florida Higher education of Medication through an settlement with the condition.

Nelson also confident staff members that the university’s posture was that vaccines are “safe and helpful, with a extremely very low risk of adverse outcomes.”

“We figure out there is from time to time substantial disagreement among experienced individuals on plan problems surrounding the COVID pandemic. Very little is more elementary to our existence as an institution of greater learning than supporting the two bedrock ideas of totally free speech and academic liberty,” the e mail stated. “As an academic wellbeing centre, we also stand for the basic principle of scientifically sound, proof-dependent health care decisions.”

Posted on

Florida says healthy kids shouldn’t get COVID vaccine, contradicting CDC

Florida says healthy kids shouldn’t get COVID vaccine, contradicting CDC

TALLAHASSEE — The Florida Department of Health is poised to officially recommend against giving coronavirus vaccines to healthy children.

Surgeon General Joseph Ladapo made the pronouncement at a Monday roundtable discussion on coronavirus mitigations policies moderated by Gov. Ron DeSantis.

Ladapo, who leads Florida’s Department of Health, said his department’s recommendation would be the first of its kind in the country. It wasn’t clear what age groups would fall under the recommendation, and neither the governor’s office nor the Department of Health released a copy of the new guidelines or responded to an email as of 5:30 p.m. Monday requesting more information.

The announcement came after a 90-minute discussion among 10 doctors and researchers who rejected the benefits of various coronavirus mitigation measures such as vaccine mandates, mask requirements and business and school closures, saying instead those policies only caused harm.

“I think what Florida’s guidance reflects is the latest research,” DeSantis told reporters at a news conference at Plant City later in the day. He said healthy kids are at low risk for the virus and that he’s seen studies showing there’s “very little benefit” for them.

The U.S. Centers for Disease Control and Prevention has approved the Pfizer-BioNTech vaccine for children ages five and older. That agency recommends vaccinating children. Vaccines for children younger than 5 have not yet been approved.

Although older people are far more likely to die from the virus than children, the CDC website notes COVID-19 is one of the top 10 causes of death for children aged 5 to 11.

More than 804,000 Florida children younger than 16 have contracted the coronavirus, according to Florida Department of Health data. Forty-two of those children died. About 373,000 Florida children ages five to 11 have gotten at least one dose of a coronavirus vaccine. That’s about 22 percent of the state’s five to 11 population.

Related: Global COVID deaths surpasses 6 million in pandemic’s third year

The panel event was billed as “The Curtain Close on COVID Theater,” and was held in a professionally lit studio in West Palm Beach with 10 guest speakers, including doctors and researchers from around the country. Among them were three authors of the Great Barrington Declaration, a highly controversial document that recommended against lockdowns because of what they said were “devastating” public health consequences.

On a floor-to-ceiling screen behind the panelists were square tiles with video feeds of attendees, many of whom were staffers at various government agencies in the DeSantis administration, including the Department of Children and Families, the Department of Economic Opportunity, the Department of Juvenile Justice and others.

Panelists touched on several themes championed by DeSantis, including what speakers called the “censorship” of doctors who dissent from the mainstream coronavirus guidance. Some accused the CDC and other government agencies of becoming politicized or of working with media outlets to buy “surreptitious advertising” promoting vaccines.

Get insights into Florida politics

Get insights into Florida politics

Subscribe to our free Buzz newsletter

Political editor Emily L. Mahoney will send you a rundown on local, state and national politics coverage every Thursday.

You’re all signed up!

Want more of our free, weekly newsletters in your inbox? Let’s get started.

Explore all your options

Robert Malone, a vaccine researcher who has become a vocal proponent of the anti-vaccine movement during the pandemic, said the “deep state” has kept doctors from using “repurposed drugs” like hydroxychloroquine to treat COVID-19. Numerous studies have found that drug has no clinical benefit in fighting the virus.

Related: Who is Robert Malone? Joe Rogan’s guest was a vaccine scientist, became an anti-vaccine darling

Multiple panelists said that a large portion of school children have already been infected with COVID-19, and said that natural immunity is one strong reason for kids not to need vaccines.

One panelist, a California doctor named Tracy Beth Høeg, talked about a study that she authored on the risks of myocarditis, an inflammation of the heart muscle, after some people, especially boys, received coronavirus vaccines.

“Even for boys who are previously healthy who haven’t been previously infected, we didn’t find that there was a benefit (to getting vaccinated), there was actually overall risk of giving them the second dose,” she said.

Høeg’s study has not been peer-reviewed, and PolitiFact reported that flawed data and potential conflicts of interest may have impacted the researchers’ findings.

Notably, hospitalization rates were calculated from January to July 2021, prior to the delta and omicron waves in much of the country. The delta and omicron variants pose more risk to children than previous variants.

Related: Doubts raised over preprint study regarding myocarditis risk in teenage boys

Another speaker, Joseph Fraiman, an emergency room doctor in Louisiana, said the “severe” side-effects of the vaccines compared to the mild symptoms caused by the coronavirus in children means there’s no “clear benefit.”

“If you have a healthy child, the chances of that child dying are incredibly low, essentially close to zero if not actually zero,” he said. Fraiman then bashed the U.S. Food and Drug Administration for not doing enough research on the coronavirus vaccine, saying it’s left a vacuum of information.

“We have no idea if vaccines reduce transmission in kids or in adults,” he said.

The White House responded to Ladapo’s announcement during a media briefing later Monday afternoon.

“It’s deeply disturbing that there are politicians peddling conspiracy theories out there and casting doubt on vaccinations when it is our best tool against the virus and the best tool to prevent even teenagers from being hospitalized,” press secretary Jen Psaki said.

Sonja Rasmussen, a pediatrician and epidemiologist at the University of Florida, said in an interview that she did not support the state’s recommendation. She noted that the American Academy of Pediatrics recommends COVID-19 vaccines for eligible children and adolescents 5 years of age or older.

“Children are at lower risk than adults but they’re certainly not at no risk,” Rasmussen said. “We have a safe and effective vaccine with a very low risk of adverse outcomes.”

Rasmussen noted that children have not been immune to hospitalization from COVID-19, and many have experienced so-called “long COVID.” The CDC has found that unvaccinated 12-to-17-year-olds are more than twice as likely to have been hospitalized from COVID-19 than those who are fully vaccinated.

And a 2020 survey from the United Kingdom Office of National Statistics estimated more than 1 in 10 children experience COVID symptoms 5 weeks after infection.

Rasmussen disputed the panelists’ contentions related to the safety of the vaccines. For example, she pointed to a December study published in the Journal of the American Medical Association that showed that the risk of myocarditis in children is relatively low — 70 cases per million vaccine doses in boys aged 12 to 15. Those cases of myocarditis were largely milder than instances of that heart condition brought on by viruses like COVID-19, the study noted.

She noted that much about the virus remains uncertain. For example, it’s unclear how long the vaccines offer peak protection. Kids may need boosters at some point, Rasmussen said.

But Rasmussen said the vaccines are safe and effective. If parents have questions, they should consult their family doctor, she said.

Ladapo and the other panelists on Monday derided the experts and government officials that have pushed for vaccine mandates and closures, even in the early days of the pandemic.

“I still remember very clearly when people were telling us, including a lot of people with a lot of degrees (who) were telling us, ‘15 days to stop the spread,’ ” Ladapo said, referencing the Trump administration’s campaign in March 2020 encouraging people who were medically vulnerable or who felt sick to stay home to combat the coronavirus. “These people had no idea what they were talking about.”

He said now, people in power “want us to forget that their choices that they made for everyone were the wrong choices that basically led to no appreciable benefit.”

Times staff writers Ian Hodgson and Romy Ellenbogen, as well as Miami Herald Washington reporter Bryan Lowry, contributed to this report.

Posted on

Novavax COVID-19 vaccine (Nuvaxovid): Data on side effects

New vaccines for COVID-19 are emerging. One such vaccine is Novavax. Early studies indicate that it may have similar efficacy to the Pfizer and Moderna vaccines but fewer side effects. Further trials and analyses of the initial results are underway to understand its effects better.

Share on Pinterest
What side effects can the Novavax vaccine cause? Image credit: Mariano Vimos/Vizzor Image/Getty Images.

Medical News Today has contacted over 20 experts for comment on the potential side effects of the Novavax COVID-19 vaccine, Nuvaxovid. As of the time of publication, they have declined to comment until additional peer-reviewed data become available.

On January 31, 2022, Novavax submitted a request to the Food and Drug Administration (FDA) for emergency use authorization for its COVID-19 vaccine candidate.

Over 30 countries, including the United Kingdom, Australia, and Germany, have already approved this vaccine for emergency use.

Unlike mRNA vaccines, such as Pfizer and Moderna, the Novavax vaccine uses a longer-standing protein-based technology. The flu vaccine and the hepatitis B vaccine, which doctors have administered throughout the U.S. since 1986, use this technology.

The proteins inside the Novavax vaccine mimic COVID-19’s spike protein. They were created in moth cells and then assembled into nanoparticles – small particles made of a few hundred atoms. While they share COVID-19’s molecular structure, they do not replicate or cause COVID-19.

The vaccination involves injecting the nanoparticles into arm muscles alongside a compound extracted from the soapbark tree, which acts as an adjuvant to attract immune cells to the injection site.

A full course of the vaccine requires two doses taken 3 weeks apart.

The results from two large phase 3 trials on Novavax have been published.

One trial in the United States and Mexico included 29,949 participants ages 18 and over who had not previously contracted SARS-CoV-2. On a ratio of 2:1, they received two doses of either the Novavax vaccine or a placebo.

Overall, the researchers found that the Novavax vaccine was 92.6{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} effective against the Alpha and Beta variants of the virus. They also tracked side effects for 7 days after each dose.

While side effects occurred after the first dose, they were more common after the second dose. Common side effects included:

  • tenderness at the injection site for 73{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of participants
  • pain upon and after vaccination for 60{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of participants
  • fatigue for 50{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of the participants
  • muscle pain for 48{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of participants
  • headache for 44{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of participants
  • malaise for 39{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of participants

Less common side effects after the second dose included:

  • fever for 6{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of participants, including severe cases for 0.37{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809}
  • nausea and vomiting for 11{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of participants, including severe cases for 0.23{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809}
  • joint pain for 22{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of participants, including severe cases for 2.44{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809}

A smaller trial including 15,187 participants in the UK found similar results.

Data so far suggest, that on the whole, the Novavax vaccine may have fewer side effects than both the Pfizer and Moderna vaccines.

After a second dose of the Pfizer vaccine:

  • 66{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} reported pain
  • 60{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} fatigue
  • 52{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} headache
  • 38{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} muscle pain
  • 22{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} joint pain
  • 16{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} fever
  • 2{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} vomiting.

Meanwhile, after a second dose of the Moderna vaccine:

  • 88{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} experienced pain
  • 16{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} fever, including 1.4{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} severe cases
  • 59{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} headache
  • 66{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} fatigue
  • 43{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} joint pain
  • 19{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} vomiting.

Like the Novavax vaccine, side effects were more common after the second vaccine dose.

The World Health Organization (WHO) recommends Novavax for:

  • those living with conditions that increase the risk of severe COVID-19, such as cardiovascular disease, respiratory disease, and diabetes
  • people who have contracted COVID-19 in the past
  • people who are breastfeeding and those who are not

The WHO the following not to get the vaccine:

  • people with a history of anaphylaxis to any component inside the vaccine
  • people with symptomatic PCR-confirmed COVID-19 until they have recovered and finished self-isolation
  • people with a body temperature of over 38.5°C until they no longer have a fever
  • people under 18 years old, as research studying its safety and efficacy is still underway.

The WHO also highlights that data on having the vaccine during pregnancy is not yet available. However, as other protein-based vaccines have comparable efficacy in pregnant and non-pregnant people, they say that the Novavax vaccine may be the same.

Therefore, they recommend that pregnant people receive information about the risks of COVID-19 during pregnancy, the potential benefits of vaccination, and safety data limitations so that they can make their own decision. However, they recommend pregnant people get vaccinated in situations where the benefits outweigh the risks.

Any side effects from the vaccine were largely mild to moderate and transient. The phase 3 trial in the U.S. and Mexico, and the U.K did not raise any safety concerns.

According to Prof. Paul Heath, professor of paediatric infectious diseases and director of the Vaccine Institute, St George’s, University of London and St George’s Hospital, London, and chief investigator of the Novavax United Kingdom trial:

“The results are very reassuring and importantly show that this vaccine appears to be safe and effective in populations from a range of communities and demographic groups, and those with a range of underlying comorbidities, now (across both trials) with a total number of participants of more than 45,000.”

“Both the U.K. and the US. and Mexico trials used the same case definitions, and these consistent results, therefore, provide much confidence in the use of this vaccine for the global population. We now await the peer-reviewed publication. We also look forward to the results of the trial’s adolescent arm (12–17 years), which recently completed enrolment,” Prof Heath adds.

According to Dr. Peter English, a retired consultant in communicable disease control, former editor of Vaccines in Practice, and immediate past chair of the BMA Public Health Medicine Committee:

“[t]he vaccine is a much more traditional sort of vaccine than the mRNA and vector vaccines currently in use. The actual spike protein is injected, in the form of nanoparticles, instead of inserting the genetic material enabling our cells to create the spike protein.”

He adds that:

“It remains to be seen whether this will have consequences in terms of real-world effectiveness or safety; but the more different types of vaccine we have, the greater our ability will be to optimize effectiveness and safety in different groups.”

For live updates on the latest developments regarding the novel coronavirus and COVID-19, click here.

Posted on

Pfizer and BioNTech seeking emergency use authorization from FDA for Covid-19 vaccine for children younger than 5

Pfizer and BioNTech explained they have initiated a rolling submission of knowledge to the US Foodstuff and Drug Administration immediately after a ask for from the agency. They expect to complete the EUA submission in the coming days and say they will also post medical trial information to the European Medications Agency and other businesses about the world.

Safety and usefulness are essential, explained Dr. Paul Offit, a member of the committee and director of the Vaccine Instruction Centre at Children’s Clinic of Philadelphia.

“The self-assurance of the American general public is dependent on that, that you you might be recommending a little something that you would give to your own little ones,” Offit instructed CNN. “It all relies upon on the knowledge. The facts will tell us just how very good these are. There should be a strong basic safety profile and a sturdy efficacy profile and immunogenicity profile. And if that is genuine, velocity doesn’t really issue, as prolonged as they have those people data.”

The Pfizer/BioNTech vaccine is now authorized for use in men and women as youthful as 5 and would be the initially Covid-19 vaccine offered for the youngest young children.

The go arrives “in response to the urgent general public wellness want in this populace,” the organizations claimed in a news launch.

Since the start out of the pandemic, at the very least 11.4 million little ones have tested constructive for Covid-19, the American Academy of Pediatrics described Monday, with in excess of 3.5 million situations reported in January alone. Small children made up 22.8{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of the whole documented weekly circumstances for the week ending January 27.

“Pediatricians have viewed firsthand the concern, strain and hardship that so many family members of young youngsters have endured as they await a vaccine,” Dr. Moira Szilagyi, president of the American Academy of Pediatrics, claimed in a assertion. “We urge a clear and facts-driven method to consider this vaccine for this age group and look ahead to offering its protection to our youngest little ones.”

The corporations are continuing to take a look at a 3-dose edition of the vaccine in the youngest children.

In December, Pfizer prolonged its vaccine trial in young kids just after two child-sized doses of the vaccine did not generate the expected immunity in 2- to 5-yr-olds, even though it did so for the infants up to age 2.

The organizations explained details on a third dose given at minimum eight months following the second dose is anticipated in the coming months, which will also be submitted to the Fda.

Pfizer's child-sized vaccine fails to produce expected immunity in younger kids; company adds third dose to trials

“As hospitalizations of small children underneath 5 due to COVID-19 have soared, our mutual purpose with the Fda is to get ready for long run variant surges and supply moms and dads with an possibility to aid defend their small children from this virus,” Pfizer Chairman and CEO Albert Bourla mentioned. “Ultimately, we consider that 3 doses of the vaccine will be required for small children 6 months by 4 several years of age to reach high concentrations of security from recent and opportunity upcoming variants.

“If two doses are authorized, mother and father will have the prospect to get started a COVID-19 vaccination sequence for their little ones when awaiting likely authorization of a third dose.”

For people today 12 and more mature, the Pfizer/BioNTech vaccine dose is 30 micrograms of vaccine, and for little ones ages 5 to 11, it was stepped down to 10 micrograms. The dose for the youngest small children is even lessen: 3 micrograms.

CNN reported previously Tuesday that Pfizer was inspired to seek authorization for the two-dose vaccine by federal regulators, who hope the EUA can be granted by late February. Waiting around on data for a few doses could extend the hold out until March.

“If the intention of the vaccine is to get baseline immunity in the young ones — to reduce seriously undesirable results and you are seriously not using the vaccine as a resource to avert an infection in the 1st position — two doses could do that,” Dr. Scott Gottlieb, a previous Food and drug administration commissioner and existing Pfizer board member, stated on CBS on Sunday. “I feel that may possibly be why federal overall health officials are rethinking this.”

CNN’s Katherine Dillinger, John Bonifield, Jen Christensen and Brenda Goodman contributed to this report.